Overview of Breast Cancer Therapeutics MarketThe Global Breast Cancer Therapeutics Market is valued at USD 33.83 Billion in ...

Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.

As part of its long-term investment in women’s sports, Eli Lilly will be present at the WNBA All-Star Game through breast cancer awareness activations.

His family’s history with the disease has inspired his most recent activism.

Cancer conversations are evolving beyond awareness months, with increased focus on personal journeys, breakthroughs and patient experiences.

A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.

A weekend focused on women’s health and women’s basketball, all in Eli Lilly’s home state of Indiana? Consider that a layup ...

Rob Lowe shares how three generations of women in his family passed away from breast cancer. The acclaimed actor has partnered with Eli Lilly to spread awareness about the benefits of cancer ...

Success in this trial could position Eli Lilly favorably against competitors in the breast cancer treatment market, potentially leading to increased market share and revenue.

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.

Dr. Lillian Smyth, senior vice president, global development head, breast cancer, is a medical oncologist and leads the development of breast cancer medicines at Eli Lilly and Company (Lilly).